Animal model for secretory otitis media caused by gastric reflux and establishment method thereof

By non-surgical gastric juice exposure on the pharyngeal mouth of the Eustachian tube in rats, the problems of inaccurate and experimental instability of simulated gastric juice reflux in the prior art were solved, and the precise simulation and stability experimental results on the impact of gastric juice reflux were achieved. , provides a reliable animal model for the study of secretory otitis media.

CN119054648AInactive Publication Date: 2024-12-03THE SIXTH MEDICAL CENT OF THE CHINESE PEOPLES LIBERATION ARMY GENERAL HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411255146.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-09
Publication Date
2024-12-03
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

In the prior art, when establishing an animal model of secretory otitis media with gastric juice reflux, gastric juice can be simulated by injection of tympanic membrane, which cannot accurately simulate gastric juice reflux, resulting in inaccurate experimental results and may cause secondary infection, affecting stability.

Method used

Using a non-surgical method, gastric juice was exposed on the pharyngeal mucosa of the Eustachian tube in rats. Through specific injection tools and endoscopic guidance, the effect of gastric juice reflux on the Eustachian tube is accurately simulated, and the secretion caused by gastric juice reflux is established. Animal model of otitis media.

Benefits of technology

Accurate simulation of the impact of gastric juice reflux on the structure and function of the Eustachian tube is achieved, the stability and reliability of the experimental results are improved, secondary infection is avoided, and more realistic pathological observation and research data are provided.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119054648A_ABST
    Figure CN119054648A_ABST
Patent Text Reader

Abstract

The invention relates to an animal model for secretory otitis media caused by gastric reflux and an establishment method of the animal model, and belongs to the technical field of animal model establishment. Aiming at the problems of inaccurate experimental results, secondary infection and the like during modeling of animals with secretory otitis media caused by gastric reflux at present, a non-surgical method is adopted and comprises the following steps: feeding experimental rats according to standard requirements, fasting water for 8 hours, and then performing anesthesia treatment; performing ear endoscope examination on the anesthetized experimental rats, and marking the experimental rats without otitis media performance; performing simulated gastric juice injection on the marked experimental rat by adopting a specific injection tool; after successful injection, post-treatment is carried out on the experimental rat, establishment of the animal model of secretory otitis media caused by gastric juice reflux is completed, gastric juice is exposed on the pharyngeal mucosa of the Eustachian tube of the rat by using the method, so that the possible influence of gastric juice reflux on the structure and function of the Eustachian tube is simulated, and the experimental rat model of secretory otitis media caused by gastric juice reflux is established. And a foundation is laid for researching the relationship between long-term gastric reflux and secretory otitis media.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of animal model construction, and in particular to an animal model of secretory otitis media caused by gastric juice reflux and a method for establishing the model. Background Art

[0002] Secretory otitis media is a non-suppurative lesion of the middle ear. It is a common and frequent disease in the Department of Otolaryngology. The cause is often related to the abnormal function of the Eustachian tube. The "pharynx" in Eustachian tube refers to the nasopharynx, and the "drum" refers to the tympanic cavity of the middle ear. The Eustachian tube is a passage from the nasopharynx to the tympanic cavity of the middle ear. When the Eustachian tube cannot work properly, it cannot regulate the air pressure in the tympanic cavity well, making the pressure in the tympanic cavity less than the atmospheric pressure. The blood vessels in the ear expand due to the low pressure, resulting in fluid exudation and the formation of secretory otitis media.

[0003] This disease is more common in children. Since the Eustachian tube of children is short, flat and wide, about 90% of children have suffered from secretory otitis media before school age and have an average of 4 attacks per year. Adults often suffer from Eustachian tube dysfunction caused by rhinitis and chronic inflammation of the nasopharynx, which is a common disease among middle ear diseases. The causes of secretory otitis media are relatively complex. One is the pressure and blockage of the pharyngeal opening of the Eustachian tube, such as adenoids hypertrophy, hypertrophic rhinitis, nasopharyngeal tumors or lymphatic hyperplasia; the second is secondary to upper respiratory tract infection; the third is after radiotherapy of the head and neck, due to swelling of the nasopharyngeal and Eustachian tube mucosa, local venous and lymphatic reflux disorders, resulting in stenosis of the organ cavity.

[0004] In addition to the above common causes of secretory otitis media, gastroesophageal reflux (also known as gastric reflux) can also cause otitis media. Gastroesophageal reflux disease is a multidisciplinary disease, which is mainly caused by the reflux of gastric contents into the esophagus through the cardia, entering the throat, mouth, and airway, causing clinical symptoms and complications, and causing clinical manifestations of esophageal bloating. Among them, the refluxed substances enter the throat through the esophagus and can enter the middle ear through the Eustachian tube. The acidic substances will form local irritation and produce an inflammatory reaction, which may lead to the occurrence of otitis media.

[0005] However, there are few basic studies on gastric reflux-induced secretory otitis media by scholars at home and abroad, and the pathogenesis is still unclear; when a small number of researchers establish animal models for this disease, they usually inject simulated gastric juice through the tympanic membrane to allow the simulated gastric juice to flow through the middle ear to the Eustachian tube (such as Figure 1 This modeling method is not in line with the normal physiological mechanism of gastric reflux and secretory otitis media. It will expose the entire mucosal surface of the Eustachian tube to the simulated gastric juice, prolonging the exposure range and time, and artificially expanding the experimental results. Secondly, this method will cause the tympanic membrane needle hole to be unable to heal through tympanic membrane injection, and long-term exposure will cause secondary infection of the middle ear, affecting the stability of the experimental results.

[0006] In view of this, selecting and establishing an effective animal model will not only help to further understand the pathogenesis and evolution of the disease, but also provide a theoretical basis for the selection of clinical treatment options. Summary of the invention

[0007] In order to solve the problems existing in the above-mentioned background technology, the present invention aims to propose an animal model of secretory otitis media caused by gastric reflux and a method for establishing the same. A non-surgical method is used to expose gastric juice to the pharyngeal mucosa of the Eustachian tube of rats to simulate the possible effects of gastric reflux on the structure and function of the Eustachian tube, thereby accurately simulating the gastric reflux phenomenon that may occur in the human body, and exploring the specific effects of this gastric reflux on the structure and function of the Eustachian tube and its relationship with secretory otitis media.

[0008] The present invention achieves the above technical objectives by adopting the following technical solutions: A method for establishing an animal model of secretory otitis media caused by gastric reflux comprises the following steps: S1: Experimental rats were raised according to standard requirements and anesthetized after being deprived of food and water for 8 hours; S2: Perform ear endoscopy on the anesthetized experimental rats and mark the experimental rats without otitis media. S3: Use a specific injection device to inject simulated gastric fluid into the marked experimental rats; S4: After the successful injection of simulated gastric juice, the experimental rats were post-treated to complete the establishment of the animal model of secretory otitis media caused by gastric juice reflux.

[0009] As a further preferred embodiment of the above technical solution: in step S1, sodium pentobarbital with a concentration of 1% is used for anesthesia, and the injection amount is converted to a dose of 0.45 mL / 100 g based on the body weight of the experimental rat. After anesthesia, the tongue of the experimental rat is pulled out.

[0010] As a further preferred embodiment of the above technical solution: in step S3, the specific injection device includes a syringe and a specific needle, the specific needle and the syringe are detachably connected, the specific needle is a 13mm long 32G needle, and the front end of the specific needle is bent into 90° at 4mm.

[0011] As a further preferred embodiment of the above technical solution: in step S3, the specific process of injecting simulated gastric fluid into the labeled experimental rats includes: S31: Clean oral foreign matter and secretions and disinfect the soft palate of the marked experimental rats; S32: inserting a nasal endoscope into the oral cavity of the experimental rat treated in step S31, and under the guidance of the nasal endoscope, placing the front end of the specific needle horizontally with the soft palate of the experimental rat, and exploring the pterygoid hook along the outer edge of the soft palate; S33: When the specific needle reaches the pterygoid hook of the experimental rat, 1 mm behind the pterygoid hook, the specific needle is vertically inserted into the soft palate and reaches the nasal cavity by rotating the syringe; S34: Inject the simulated gastric fluid in the syringe into the nasal cavity of the experimental rat, and stop the injection when liquid overflows from the nasal cavity; S35: The same method was used to inject simulated gastric fluid into the contralateral soft palate of the experimental rats.

[0012] A further preferred implementation is: in step S31, before cleaning the oral foreign matter and secretions and disinfecting the soft palate of the experimental rat, the experimental rat is fixed in a supine position, the oral cavity is opened with an opener, and the tongue of the experimental rat is fixed on one side after being pulled out.

[0013] As a further preferred embodiment of the above technical solution: in step S4, the specific process of post-processing the experimental rats includes: S41: Use a sterile cotton swab to press the specific puncture point after the needle is pulled out, and remove the opener after bleeding stops; S42: Observe the eardrums of both ears of the experimental rats through an otoscope and check if there is anything abnormal.

[0014] In addition, the present invention also proposes an animal model of secretory otitis media caused by gastric reflux obtained by any of the above disclosed establishment methods.

[0015] Compared with the prior art, the present invention has the following beneficial effects: 1. The present invention uses a non-surgical experimental method, cooperates with endoscopic guidance in the oral cavity of experimental rats, and accurately completes the injection of simulated gastric juice through the special angle of the needle of a specific injection device and accurate bony positioning, thereby achieving the purpose of directly exposing the simulated gastric juice to the pharyngeal mucosa of the Eustachian tube of the experimental rats, and effectively overcomes the disadvantages of inaccurate experimental results and secondary infection caused by tympanic membrane injection of simulated gastric juice flowing to the Eustachian tube.

[0016] 2. The modeling method of the present invention is simple to operate, causes less harm to experimental rats, and is more conducive to the stability of experimental results. The experimental rats can eat normally after waking up, and the operation can be performed multiple times on the same experimental rats. It provides a stable animal model for studying the relationship between long-term gastric reflux and secretory otitis media, facilitates long-term observation of the effect of gastric reflux on secretory otitis media, and is conducive to the study of the mechanism of action and pathological evolution of this disease.

[0017] 3. The animal model of the present invention can be used to accurately simulate the gastric reflux phenomenon that may occur in the human body, and explore the possible effects of the gastric reflux on the structure and function of the Eustachian tube. The mechanism of action of gastric reflux on the pharyngeal mucosa of the Eustachian tube can be more realistically replicated and observed, and the changing pattern of this physiological process in the human body when affected by gastric reflux can be deeply understood, providing reliable data support and theoretical basis for subsequent research. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required for use in the embodiments are briefly introduced below.

[0019] Figure 1 A schematic diagram of the direction of the method for establishing an animal model commonly used in the background technology; Figure 2 A schematic diagram of the direction of the method for establishing an animal model of the present invention; Figure 3 It is a schematic diagram of determining the injection position by bone landmarks during modeling in the present invention; Figure 4 It is a schematic diagram of the present invention vertically piercing into the soft palate of a rat to reach the nasal cavity after reaching the injection position during modeling; Figure 5 This is the experimental operation process 1 in the embodiment of the present invention; Figure 6 This is the experimental operation process 2 in the embodiment of the present invention; Figure 7 This is the experimental operation process three in the embodiment of the present invention; Figure 8 The HE staining results of the control group and the experimental group of experimental rats in the embodiment of the present invention are shown; Fig. 9 AB-PAS staining results of the control group and the experimental group of experimental rats in the examples of the present invention. DETAILED DESCRIPTION

[0020] In order to make the purpose, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the accompanying drawings of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all of the embodiments.

[0021] The research on experimental rats in the following examples, as well as the design and implementation of various animal experiments, are in accordance with animal welfare and ethical principles, that is, complying with animal protection principles, animal welfare principles and ethical principles. In addition, the reagents involved in the following examples are all commercially available products, except those explicitly stated, and can be purchased through regular channels.

[0022] The experimental rats used were SPF-grade SD rats from Sibeifu (Beijing) Biotechnology Co., Ltd., male, 5 weeks old, experimental rat license number: SCXK (Beijing) 2019-0010. They were kept in a ventilated environment with controlled temperature (22°C), humidity (50-70%), and appropriate light-dark cycle (12 hours light / 12 hours dark cycle).

[0023] Experimental equipment: 13 mm long 32G needle, rat fixation frame, artificial gastric juice SGF (sterile) (solarbio, A7921), 1 mL syringe.

[0024] Reference Figure 1-4 The present invention provides a method for establishing an animal model of secretory otitis media caused by gastric reflux, comprising the following steps: S1: Experimental rats were raised according to standard requirements and anesthetized after being deprived of food and water for 8 hours; S2: Perform ear endoscopy on the anesthetized experimental rats and mark the experimental rats without otitis media. S3: Use a specific injection device to inject simulated gastric fluid into the marked experimental rats; S4: After the successful injection of simulated gastric juice, the experimental rats were post-treated to complete the establishment of the animal model of secretory otitis media caused by gastric juice reflux.

[0025] Furthermore, in step S1, all experimental rats were housed in separate cages, with 4 rats in each cage, in a quiet, ventilated environment with an air filtration system. The ambient temperature was controlled at 20±2°C and the humidity was maintained at 55% to 65%. In order to maintain the animals' circadian biological rhythm, the lights in the laboratory were turned on from 8:00 to 20:00 every day, and turned off from 20:00 to 8:00 the next day. The rats were fed with standard rodent feed, and were allowed to drink water and eat freely during the feeding period. The adaptive feeding lasted for 3 days.

[0026] The rats were fasted from food and water for 8 hours before the operation, and then they were given general anesthesia. The anesthesia was treated with 1% sodium pentobarbital, and the injection volume was calculated as 0.45mL / 100g based on the body weight of the rats. After anesthesia, the tongue of the rat was pulled out. When the corneal reflex of the rat disappeared, there was no pain response to stimulation, and the breathing and heartbeat were stable, it indicated that the anesthesia was successful. The rats were placed on their side with their tongues pulled out to prevent death from suffocation due to the tongue falling back.

[0027] In step S2, a preoperative evaluation is performed on the anesthetized experimental rats. Specifically, after the experimental rats are successfully anesthetized, a 0° ear endoscopy is performed to check the eardrums of both ears of the experimental rats. It is observed that the eardrums of both ears are free of congestion, effusion, yellowing, etc., confirming that the experimental rats have no symptoms of otitis media, and they are marked for subsequent processing.

[0028] In step S3, the labeled experimental rats are injected with simulated gastric fluid using a specific injection device, such as Figure 2-4 As shown, the specific injection device includes a syringe and a specific needle. The specific needle and the syringe are detachably connected. The specific needle uses a 13mm long 32G needle, and the front end of the specific needle is bent at 90° at 4mm. The specific operation process is as follows: 1) The experimental rats were placed in a supine position with their limbs fixed on a foam board and their heads slightly tilted back. The mouth was opened with an opener and the tongue was fixed on one side after being pulled out to fully expose the operation field of view. Foreign bodies and secretions in the mouth were cleaned with an aspirator, and the soft palate was disinfected with povidone-iodine solution. 2) Insert the nasal endoscope into the oral cavity of the experimental rat. Under the guidance of the nasal endoscope, place the bend of the front end of the specific needle in the deep oral cavity, keeping it level and parallel to the soft palate of the experimental rat, and probe along the outer edge of the soft palate to the hook of the pterygoid process (such as Figure 3 The red arrow in the middle indicates the area where the rat's soft palate surface blood vessels are avoided during the needle insertion process; 3) When the specific needle reaches the pterygoid hook of the experimental rat, 1 mm behind the pterygoid hook, the outer end of the syringe is rotated to make the specific needle vertically penetrate into the soft palate of the experimental rat and reach the nasal cavity, such as Figure 4 As shown; 4) Inject the simulated gastric fluid in the syringe into the nasal cavity of the experimental rat. When a small amount of liquid overflows from the nasal cavity, the injection is successful. Stop the injection at this time. 5) The same method was used to inject simulated gastric juice into the contralateral soft palate of the experimental rats, and the two ears of the experimental rats were modeled simultaneously.

[0029] In step S4, the post-treatment of the experimental rats is specifically as follows: when the injection is completed and the specific needle is taken out, the acupuncture point after the needle is removed is pressed with a sterile cotton swab, and the ear opener is removed after observing no active bleeding. The eardrums of both ears of the experimental rats are observed through an otoscope. If there is no congestion, effusion, or blood accumulation, it means that the model is successful.

[0030] The method of the present invention simultaneously models the two ears of experimental rats, and the animals suffer less pain, which can effectively save experimental rats and scientific research funds. By simultaneously modeling the two ears of experimental rats, comparative experiments on the left ear and the right ear can be carried out in the same animal, which can greatly reduce the error of the experimental results and improve the reliability of the data. By comparing the different reactions of the two ears under the same experimental conditions, the effect of gastric reflux on secretory otitis media can be more accurately evaluated, and the potential mechanism of gastric reflux on secretory otitis media can be deeply studied. Example

[0031] Reference Figure 5-9 , the following experiments were performed according to the animal model establishment method of the present invention: Bend the front end of a 13mm long 32G needle to 90° at 4mm. After connecting the needle to the syringe, insert the front end of the needle horizontally into the oral cavity of the experimental rat under the guidance of the nasal endoscope and extend it along the edge of the soft palate of the rat to probe the hook of the pterygoid process. Figure 6 The pterygoid hook protrusion can be seen in the middle. When the needle reaches the pterygoid hook, it is positioned 1 mm behind it and inserted vertically into the soft palate. The simulated gastric fluid in the syringe is injected into the nasal cavity of the experimental rat. Clear blood vessels on the soft palate can be seen under the nasal endoscope. The blood vessels are avoided during injection to reduce intraoperative bleeding. The contralateral soft palate of the rat is injected with simulated gastric fluid in the same way, and the two ears of the experimental rat are modeled simultaneously.

[0032] The method of the present invention can well reflect the pathological changes after gastric juice refluxes to the pharyngeal opening of the Eustachian tube, and can simultaneously model the two ears of the same rat to compare the results, thereby reducing the error of the experimental results. In addition, the same rat can be injected multiple times to simulate the effects of multiple refluxes and single refluxes on the pharyngeal opening of the Eustachian tube.

[0033] In this embodiment, rats were divided into a control group and an experimental group. Under the same conditions, the rats in the experimental group were injected with simulated gastric juice using the modeling method of the present invention. The rats in the experimental group were divided into a group 3 days after modeling, a group 7 days after modeling, and a group 14 days after modeling. After the modeling was successful, the rats were routinely killed. The following is the specific treatment process of the experimental rats: 1) After the experimental rats were anesthetized, they were decapitated and then 1 ml of paraformaldehyde was injected into the tympanic membrane of the experimental rats for Eustachian tube perfusion fixation. The rat heads were evenly divided into two halves along the midline, immersed in 50 ml of paraformaldehyde, and placed in a 4°C refrigerator for full fixation for 24 hours before use; 2) Decalcify the fixed specimens and change the decalcification solution every day. After 3 days, the bone around the Eustachian tube will be soft. Remove the excess tissue under a stereo microscope, leaving only the Eustachian tube and a small amount of surrounding tissue. After 7 days of decalcification, proceed to the next step. 3) Perform HE operation on the decalcified Eustachian tube and a small amount of surrounding tissue: ①Dehydration, transparency, wax dipping: Dehydrate with 50%, 65%, 80%, 95%, and 100% ethanol solutions, respectively, and then transfer to paraffin solution after being transparentized with xylene solution. Place the long axis of the Eustachian tube specimen perpendicular to the bottom of the paraffin embedding box. After the bottom layer of paraffin solidifies and the specimen position is fixed, cover the paraffin embedding box and mark the specimen number. Fill the paraffin solution and cool it to solidify. Take out the paraffin block after 2 hours. Slice thickness: After trimming, select a slice thickness of 5 μm; Spreading: Move the cut wax film into a constant temperature water bath at 40-48℃ using ophthalmic curved forceps and a brush to spread the slices; Fishing and baking: stick the wax film on the slide.

[0034] ② Dewaxing of paraffin sections: After soaking in xylene, transfer to a descending gradient ethanol solution of 100%, 95%, 80%, 65%, and 50%, and rinse with running water.

[0035] ③Hematoxylin-eosin staining After dewaxing, the specimens were stained with HE (Solarbio, G1120).

[0036] ④AB-PAS staining After dewaxing, the specimens were stained with AB-PAS (Solarbio, G1285).

[0037] The above-mentioned HE-stained Eustachian tube and a small amount of surrounding tissue were observed under a biological microscope. Figure 8 a- Figure 8 d It can be found that the pseudostratified ciliated columnar epithelium of the Eustachian tube of the control group rats is neatly arranged, and there is no lodging or loss of cilia ( Figure 8 a) The eustachian tube mucosal epithelium of the experimental group rats was arranged neatly 3 days after modeling, and the cilia were not missing or lodged ( Figure 8 b) The cilia of the eustachian tube mucosa epithelium in the group 7 days after modeling were disordered, some of them were in a prostrate state, and there was no obvious loss of cilia ( Figure 8 c), 14 days after modeling, the cilia of the Eustachian tube mucosa epithelium in the group returned to an orderly arrangement ( Figure 8 d); This result shows that the simulated gastric juice causes the cilia function of the Eustachian tube mucosal epithelium of the experimental rats to be damaged, the swinging ability is reduced, and the defense function is reduced, resulting in the inability to excrete substances in the middle ear normally, thereby causing the onset of otitis media.

[0038] AB-PAS staining is a staining method that can mark mucus (goblet cells). The Eustachian tube and a small amount of surrounding tissue stained with AB-PAS are observed under a biological microscope. Fig. 9 a- Fig. 9 dObservation shows that compared with the control group ( Fig. 9 Compared with a), the number of goblet cells in the experimental group increased significantly 3 days after modeling, the submucosal glands proliferated, the volume increased, the mucus secretion increased, and a large amount of accumulation ( Fig. 9 b), 7 days after modeling ( Fig. 9 c) compared with the 14-day group ( Fig. 9 d) The difference was small compared with the control group; this indicates that simulated gastric fluid can lead to an increase in the number of goblet cells in the Eustachian tube, an increase in the size of goblet cells, and increased mucus secretion, which is an important cause of secretory otitis media.

[0039] The detailed description of the above embodiments is not intended to limit the scope of the invention claimed for protection, but merely represents selected embodiments of the invention. Based on the embodiments in the present invention, it is only used to illustrate the technical solution of the present invention rather than to limit it. Other modifications or equivalent substitutions made by ordinary technicians in the field to the technical solution of the present invention, as long as they do not depart from the spirit and scope of the technical solution of the present invention, should be included in the scope of the claims of the present invention.

Claims

1. A method for establishing an animal model of secretory otitis media caused by gastric reflux, characterized in that: The following steps are involved: S1: Experimental rats were raised according to standard requirements and anesthetized after being deprived of food and water for 8 hours; S2: Perform ear endoscopy on the anesthetized experimental rats and mark the experimental rats without otitis media. S3: Use a specific injection device to inject simulated gastric fluid into the marked experimental rats; S4: After the successful injection of simulated gastric juice, the experimental rats were post-treated to complete the establishment of the animal model of secretory otitis media caused by gastric juice reflux.

2. The method for establishing an animal model of secretory otitis media caused by gastric reflux according to claim 1, characterized in that: In step S3, the specific injection device includes a syringe and a specific needle. The specific needle is detachably connected to the syringe. The specific needle is a 13mm long 32G needle, and the front end of the specific needle is bent into 90 degrees at 4mm.

3. The method for establishing an animal model of secretory otitis media caused by gastric reflux according to claim 1, characterized in that: In step S3, the specific process of injecting simulated gastric fluid into the marked experimental rats includes: S31: Clean oral foreign matter and secretions and disinfect the soft palate of the marked experimental rats; S32: inserting a nasal endoscope into the oral cavity of the experimental rat treated in step S31, and under the guidance of the nasal endoscope, placing the front end of the specific needle horizontally with the soft palate of the experimental rat, and exploring the pterygoid hook along the outer edge of the soft palate of the experimental rat; S33: When the specific needle reaches the pterygoid hook of the experimental rat, 1 mm behind the pterygoid hook, the specific needle is vertically inserted into the soft palate and reaches the nasal cavity by rotating the syringe; S34: Inject the simulated gastric fluid in the syringe into the nasal cavity of the experimental rat, and stop the injection when liquid overflows from the nasal cavity; S35: The same method was used to inject simulated gastric fluid into the contralateral soft palate of the experimental rats.

4. The method for establishing an animal model of secretory otitis media caused by gastric reflux according to claim 3, characterized in that: In step S31, before cleaning the oral foreign matter and secretions and disinfecting the soft palate of the experimental rat, the experimental rat is fixed in a supine position, the oral cavity is opened with an opener, and the tongue of the experimental rat is fixed on one side after being pulled out.

5. The method for establishing an animal model of secretory otitis media caused by gastric reflux according to claim 4, characterized in that: In step S4, the process of post-processing the experimental rats includes: S41: Use a sterile cotton swab to press the specific puncture point after the needle is pulled out, and remove the opener after bleeding stops; S42: Observe the eardrums of both ears of the experimental rats through an otoscope and check if there is anything abnormal.

6. An animal model of secretory otitis media caused by gastric reflux, characterized in that: Obtained by the establishment method as described in any one of claims 1-5.